全体要約
最新の調査報告書によると、2022年の世界の嚢胞性線維症診断検査市場は、地域別および市場セクター別に分析され、2023年から2029年の予測が示されています。市場は遺伝子検査、糞便検査、免疫反応性トリプシノーゲン（IRT）検査、汗塩素検査、肺機能検査などのタイプに分かれ、病院や診断ラボなどのアプリケーションに応じた成長機会が強調されています。
アメリカ、ヨーロッパ、中国の市場はそれぞれ2022年から2029年にかけて成長が見込まれています。主要な企業にはQuidel Corporation、Quest Diagnostics、Creative Diagnosticsなどがあり、2022年には上位2社が市場の大部分を占めています。市場の成長は、製品セグメンテーション、企業の形成、収益、シェア、最新の開発、M&A活動に関連する重要なトレンドによって影響を受けています。
関連する質問
Quidel Corporation, Quest Diagnostics, Creative Diagnostics, Invitae Corporation, Asper Biogene, GeneDx, Illumina, Elucigene Diagnostics, BillionToOne Inc., ELITechGroup
製品セグメンテーションの重要なトレンド, 主要企業の戦略分析, 地域別市場の成長機会
概要
このインサイトレポートは、世界の嚢胞性線維症診断テストの状況に関する包括的な分析を提供し、製品セグメンテーション、企業の形成、収益、マーケットシェア、最新の開発およびM&A活動に関連する重要なトレンドを強調しています。このレポートはまた、嚢胞性線維症診断テストのポートフォリオや能力、市場参入戦略、市場ポジション、地理的な足跡に焦点を当てた主要なグローバル企業の戦略を分析し、加速する世界の嚢胞性線維症診断テスト市場におけるこれら企業の独自の立場をよりよく理解することを目指しています。
このインサイトレポートは、嚢胞性線維症診断テストの世界的な見通しを形作る主要な市場動向、要因、および影響要因を評価し、タイプ、用途、地域、そして市場規模ごとに予測を分解して、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的市場入力に基づく透明な方法論を用いたこの研究予測は、現在の状況と将来の軌道に関する非常に細やかな視点を提供します。
世界の嚢胞性線維症診断テスト市場の規模は、2022年のXX米ドルから2029年のXX米ドルへ成長すると予測されています；2023年から2029年にかけての年平均成長率（CAGR）はXX%と見込まれています。
アメリカ合衆国の嚢胞性線維症診断テスト市場は、2022年のXX米ドルから2029年までにXX米ドルに増加することが見込まれており、2023年から2029年までの間にXX%の年平均成長率（CAGR）を記録する見込みです。
中国の嚢胞性線維症診断検査市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%の年平均成長率（CAGR）を記録する見込みです。
ヨーロッパの嚢胞性線維症診断テスト市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年までのCAGRはXX%です。
グローバルな主要な嚢胞性線維症診断テストのプレイヤーは、クイデル社、クエスト・ダイアグノスティックス、クリエイティブ・ダイアグノスティックス、インビテ社、アスパー・バイオジーン、ジーンドックス、イルミナ、エルシジーン・ダイアグノスティックス、ビリオン・トゥ・ワン社などです。収益の面では、2022年に世界の2つの最大の企業がほぼXX%のシェアを占めました。
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、主要地域および国による嚢胞性線維症診断テスト市場の包括的な概要、市場シェア、および成長機会を提供します。
市場セグメンテーション:
タイプ別セグメンテーション
遺伝子検査
便検査
免疫反応性トリプシノゲン（IRT）テスト
汗塩素検査
肺機能検査
アプリケーション別のセグメンテーション
病院
診断研究所
その他
この報告書は地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロフィールが記載されている企業は、主要な専門家からの情報と企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されました。
クイデルコーポレーション
クエスト・ダイアグノスティクス
クリエイティブ・ダイアグノスティックス
インビテイ社
アスペルバイオジーン
ジーンデックス
イルミナ
エルシジーン・ダイアグノスティクス
ビリオンツーオネ株式会社
ELITechGroup
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの嚢胞性線維症診断検査市場規模、（2018年～2029年）
2.1.2 嚢胞性線維症診断検査市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 嚢胞性線維症診断検査セグメント、タイプ別
2.2.1 遺伝子検査
2.2.2 糞便検査
2.2.3 免疫反応性トリプシノーゲン（IRT）検査
2.2.4 汗の塩化物検査
2.2.5 肺機能検査
2.3 嚢胞性線維症診断検査市場規模：タイプ別
2.3.1 嚢胞性線維症診断検査市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの嚢胞性線維症診断検査市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 嚢胞性線維症診断検査セグメント、用途別
2.4.1 病院
2.4.2 検査室
2.4.3 その他
2.5 嚢胞性線維症診断検査市場規模：用途別
2.5.1 嚢胞性線維症診断検査市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの嚢胞性線維症診断検査市場規模、市場シェア（用途別）（2018年～2023年）
3 嚢胞性線維症診断検査市場規模：プレイヤー別
3.1 嚢胞性線維症診断検査市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける嚢胞性線維症診断検査市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける嚢胞性線維症診断検査市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの嚢胞性線維症診断検査市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 嚢胞性線維症診断検査、地域別
4.1 嚢胞性線維症診断検査市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける嚢胞性線維症診断検査市場規模成長（2018年〜2023年）
4.3 APACにおける嚢胞性線維症診断検査市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける嚢胞性線維症診断検査市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける嚢胞性線維症診断検査市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける嚢胞性線維症診断検査市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける嚢胞性線維症診断検査市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける嚢胞性線維症診断検査市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける嚢胞性線維症診断検査市場規模、地域別（2018年〜2023年）
6.2 APACにおける嚢胞性線維症診断検査市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける嚢胞性線維症診断検査市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの嚢胞性線維症診断検査 国別（2018年～2023年）
7.2 ヨーロッパにおける嚢胞性線維症診断検査市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける嚢胞性線維症診断検査市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの嚢胞性線維症診断検査 地域別（2018年～2023年）
8.2 中東・アフリカにおける嚢胞性線維症診断検査市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける嚢胞性線維症診断検査市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの嚢胞性線維症診断検査市場、市場予測
10.1 グローバルの嚢胞性線維症診断検査、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの嚢胞性線維症診断検査、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの嚢胞性線維症診断検査、市場予測
10.1.3 APACの嚢胞性線維症診断検査、市場予測
10.1.4 ヨーロッパの嚢胞性線維症診断検査、市場予測
10.1.5 中東・アフリカの嚢胞性線維症診断検査、市場予測
10.2 アメリカズの嚢胞性線維症診断検査、市場予測（国別）（2024年～2029年）
10.3 APACの嚢胞性線維症診断検査、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの嚢胞性線維症診断検査、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの嚢胞性線維症診断検査、市場予測（地域別）（2024年～2029年）
10.6 グローバルの嚢胞性線維症診断検査、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの嚢胞性線維症診断検査、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Quidel Corporation
11.1.1 Quidel Corporation：企業情報
11.1.2 Quidel Corporation：嚢胞性線維症診断検査分野の提供製品
11.1.3 Quidel Corporation：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Quidel Corporation：主要事業概要
11.1.5 Quidel Corporation：直近の展開
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics：企業情報
11.2.2 Quest Diagnostics：嚢胞性線維症診断検査分野の提供製品
11.2.3 Quest Diagnostics：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Quest Diagnostics：主要事業概要
11.2.5 Quest Diagnostics：直近の展開
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics：企業情報
11.3.2 Creative Diagnostics：嚢胞性線維症診断検査分野の提供製品
11.3.3 Creative Diagnostics：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Creative Diagnostics：主要事業概要
11.3.5 Creative Diagnostics：直近の展開
11.4 Invitae Corporation
11.4.1 Invitae Corporation：企業情報
11.4.2 Invitae Corporation：嚢胞性線維症診断検査分野の提供製品
11.4.3 Invitae Corporation：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Invitae Corporation：主要事業概要
11.4.5 Invitae Corporation：直近の展開
11.5 Asper Biogene
11.5.1 Asper Biogene：企業情報
11.5.2 Asper Biogene：嚢胞性線維症診断検査分野の提供製品
11.5.3 Asper Biogene：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 Asper Biogene：主要事業概要
11.5.5 Asper Biogene：直近の展開
11.6 GeneDx
11.6.1 GeneDx：企業情報
11.6.2 GeneDx：嚢胞性線維症診断検査分野の提供製品
11.6.3 GeneDx：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 GeneDx：主要事業概要
11.6.5 GeneDx：直近の展開
11.7 Illumina
11.7.1 Illumina：企業情報
11.7.2 Illumina：嚢胞性線維症診断検査分野の提供製品
11.7.3 Illumina：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Illumina：主要事業概要
11.7.5 Illumina：直近の展開
11.8 Elucigene Diagnostics
11.8.1 Elucigene Diagnostics：企業情報
11.8.2 Elucigene Diagnostics：嚢胞性線維症診断検査分野の提供製品
11.8.3 Elucigene Diagnostics：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Elucigene Diagnostics：主要事業概要
11.8.5 Elucigene Diagnostics：直近の展開
11.9 BillionToOne Inc
11.10 ELITechGroup
11.10.1 ELITechGroup：企業情報
11.10.2 ELITechGroup：嚢胞性線維症診断検査分野の提供製品
11.10.3 ELITechGroup：嚢胞性線維症診断検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 ELITechGroup：主要事業概要
11.10.5 ELITechGroup：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Cystic Fibrosis Diagnostic Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystic Fibrosis Diagnostic Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystic Fibrosis Diagnostic Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystic Fibrosis Diagnostic Tests and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystic Fibrosis Diagnostic Tests.
The global Cystic Fibrosis Diagnostic Tests market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cystic Fibrosis Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cystic Fibrosis Diagnostic Tests players cover Quidel Corporation, Quest Diagnostics, Creative Diagnostics, Invitae Corporation, Asper Biogene, GeneDx, Illumina, Elucigene Diagnostics and BillionToOne Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Diagnostic Tests market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segmentation by application
Hospitals
Diagnostic Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Diagnostic Tests Market Size 2018-2029
2.1.2 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cystic Fibrosis Diagnostic Tests Segment by Type
2.2.1 Genetic Tests
2.2.2 Fecal Test
2.2.3 Immunoreactive Trypsinogen (IRT) Test
2.2.4 Sweat Chloride Tests
2.2.5 Pulmonary Function Tests
2.3 Cystic Fibrosis Diagnostic Tests Market Size by Type
2.3.1 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023)
2.4 Cystic Fibrosis Diagnostic Tests Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Cystic Fibrosis Diagnostic Tests Market Size by Application
2.5.1 Cystic Fibrosis Diagnostic Tests Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023)
3 Cystic Fibrosis Diagnostic Tests Market Size by Player
3.1 Cystic Fibrosis Diagnostic Tests Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis Diagnostic Tests Revenue by Players (2018-2023)
3.1.2 Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Players (2018-2023)
3.2 Global Cystic Fibrosis Diagnostic Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystic Fibrosis Diagnostic Tests by Regions
4.1 Cystic Fibrosis Diagnostic Tests Market Size by Regions (2018-2023)
4.2 Americas Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.3 APAC Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.4 Europe Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
4.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cystic Fibrosis Diagnostic Tests Market Size by Country (2018-2023)
5.2 Americas Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
5.3 Americas Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Diagnostic Tests Market Size by Region (2018-2023)
6.2 APAC Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
6.3 APAC Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystic Fibrosis Diagnostic Tests by Country (2018-2023)
7.2 Europe Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
7.3 Europe Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Diagnostic Tests by Region (2018-2023)
8.2 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023)
8.3 Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystic Fibrosis Diagnostic Tests Market Forecast
10.1 Global Cystic Fibrosis Diagnostic Tests Forecast by Regions (2024-2029)
10.1.1 Global Cystic Fibrosis Diagnostic Tests Forecast by Regions (2024-2029)
10.1.2 Americas Cystic Fibrosis Diagnostic Tests Forecast
10.1.3 APAC Cystic Fibrosis Diagnostic Tests Forecast
10.1.4 Europe Cystic Fibrosis Diagnostic Tests Forecast
10.1.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Forecast
10.2 Americas Cystic Fibrosis Diagnostic Tests Forecast by Country (2024-2029)
10.2.1 United States Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.2 Canada Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.3 Mexico Cystic Fibrosis Diagnostic Tests Market Forecast
10.2.4 Brazil Cystic Fibrosis Diagnostic Tests Market Forecast
10.3 APAC Cystic Fibrosis Diagnostic Tests Forecast by Region (2024-2029)
10.3.1 China Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.2 Japan Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.3 Korea Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.4 Southeast Asia Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.5 India Cystic Fibrosis Diagnostic Tests Market Forecast
10.3.6 Australia Cystic Fibrosis Diagnostic Tests Market Forecast
10.4 Europe Cystic Fibrosis Diagnostic Tests Forecast by Country (2024-2029)
10.4.1 Germany Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.2 France Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.3 UK Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.4 Italy Cystic Fibrosis Diagnostic Tests Market Forecast
10.4.5 Russia Cystic Fibrosis Diagnostic Tests Market Forecast
10.5 Middle East & Africa Cystic Fibrosis Diagnostic Tests Forecast by Region (2024-2029)
10.5.1 Egypt Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.2 South Africa Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.3 Israel Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.4 Turkey Cystic Fibrosis Diagnostic Tests Market Forecast
10.5.5 GCC Countries Cystic Fibrosis Diagnostic Tests Market Forecast
10.6 Global Cystic Fibrosis Diagnostic Tests Forecast by Type (2024-2029)
10.7 Global Cystic Fibrosis Diagnostic Tests Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Information
11.1.2 Quidel Corporation Cystic Fibrosis Diagnostic Tests Product Offered
11.1.3 Quidel Corporation Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Quidel Corporation Main Business Overview
11.1.5 Quidel Corporation Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.2.3 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics Company Information
11.3.2 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.3.3 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Creative Diagnostics Main Business Overview
11.3.5 Creative Diagnostics Latest Developments
11.4 Invitae Corporation
11.4.1 Invitae Corporation Company Information
11.4.2 Invitae Corporation Cystic Fibrosis Diagnostic Tests Product Offered
11.4.3 Invitae Corporation Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Invitae Corporation Main Business Overview
11.4.5 Invitae Corporation Latest Developments
11.5 Asper Biogene
11.5.1 Asper Biogene Company Information
11.5.2 Asper Biogene Cystic Fibrosis Diagnostic Tests Product Offered
11.5.3 Asper Biogene Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Asper Biogene Main Business Overview
11.5.5 Asper Biogene Latest Developments
11.6 GeneDx
11.6.1 GeneDx Company Information
11.6.2 GeneDx Cystic Fibrosis Diagnostic Tests Product Offered
11.6.3 GeneDx Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GeneDx Main Business Overview
11.6.5 GeneDx Latest Developments
11.7 Illumina
11.7.1 Illumina Company Information
11.7.2 Illumina Cystic Fibrosis Diagnostic Tests Product Offered
11.7.3 Illumina Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina Main Business Overview
11.7.5 Illumina Latest Developments
11.8 Elucigene Diagnostics
11.8.1 Elucigene Diagnostics Company Information
11.8.2 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered
11.8.3 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Elucigene Diagnostics Main Business Overview
11.8.5 Elucigene Diagnostics Latest Developments
11.9 BillionToOne Inc.
11.9.1 BillionToOne Inc. Company Information
11.9.2 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Product Offered
11.9.3 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BillionToOne Inc. Main Business Overview
11.9.5 BillionToOne Inc. Latest Developments
11.10 ELITechGroup
11.10.1 ELITechGroup Company Information
11.10.2 ELITechGroup Cystic Fibrosis Diagnostic Tests Product Offered
11.10.3 ELITechGroup Cystic Fibrosis Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 ELITechGroup Main Business Overview
11.10.5 ELITechGroup Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Cystic Fibrosis Diagnostic Tests Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Genetic Tests Table 3. Major Players of Fecal Test Table 4. Major Players of Immunoreactive Trypsinogen (IRT) Test Table 5. Major Players of Sweat Chloride Tests Table 6. Major Players of Pulmonary Function Tests Table 7. Cystic Fibrosis Diagnostic Tests Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023) & ($ Millions) Table 9. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Table 10. Cystic Fibrosis Diagnostic Tests Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 11. Global Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023) & ($ Millions) Table 12. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Table 13. Global Cystic Fibrosis Diagnostic Tests Revenue by Players (2018-2023) & ($ Millions) Table 14. Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Player (2018-2023) Table 15. Cystic Fibrosis Diagnostic Tests Key Players Head office and Products Offered Table 16. Cystic Fibrosis Diagnostic Tests Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Cystic Fibrosis Diagnostic Tests Market Size by Regions 2018-2023 & ($ Millions) Table 20. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Regions (2018-2023) Table 21. Global Cystic Fibrosis Diagnostic Tests Revenue by Country/Region (2018-2023) & ($ millions) Table 22. Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Country/Region (2018-2023) Table 23. Americas Cystic Fibrosis Diagnostic Tests Market Size by Country (2018-2023) & ($ Millions) Table 24. Americas Cystic Fibrosis Diagnostic Tests Market Size Market Share by Country (2018-2023) Table 25. Americas Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023) & ($ Millions) Table 26. Americas Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Table 27. Americas Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023) & ($ Millions) Table 28. Americas Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Table 29. APAC Cystic Fibrosis Diagnostic Tests Market Size by Region (2018-2023) & ($ Millions) Table 30. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Region (2018-2023) Table 31. APAC Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023) & ($ Millions) Table 32. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Table 33. APAC Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023) & ($ Millions) Table 34. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Table 35. Europe Cystic Fibrosis Diagnostic Tests Market Size by Country (2018-2023) & ($ Millions) Table 36. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Country (2018-2023) Table 37. Europe Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023) & ($ Millions) Table 38. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Table 39. Europe Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023) & ($ Millions) Table 40. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Table 41. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Region (2018-2023) & ($ Millions) Table 42. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Region (2018-2023) Table 43. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Type (2018-2023) & ($ Millions) Table 44. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Table 45. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size by Application (2018-2023) & ($ Millions) Table 46. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Table 47. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Diagnostic Tests Table 48. Key Market Challenges & Risks of Cystic Fibrosis Diagnostic Tests Table 49. Key Industry Trends of Cystic Fibrosis Diagnostic Tests Table 50. Global Cystic Fibrosis Diagnostic Tests Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 51. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share Forecast by Regions (2024-2029) Table 52. Global Cystic Fibrosis Diagnostic Tests Market Size Forecast by Type (2024-2029) & ($ Millions) Table 53. Global Cystic Fibrosis Diagnostic Tests Market Size Forecast by Application (2024-2029) & ($ Millions) Table 54. Quidel Corporation Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 55. Quidel Corporation Cystic Fibrosis Diagnostic Tests Product Offered Table 56. Quidel Corporation Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 57. Quidel Corporation Main Business Table 58. Quidel Corporation Latest Developments Table 59. Quest Diagnostics Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 60. Quest Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered Table 61. Quest Diagnostics Main Business Table 62. Quest Diagnostics Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 63. Quest Diagnostics Latest Developments Table 64. Creative Diagnostics Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 65. Creative Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered Table 66. Creative Diagnostics Main Business Table 67. Creative Diagnostics Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 68. Creative Diagnostics Latest Developments Table 69. Invitae Corporation Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 70. Invitae Corporation Cystic Fibrosis Diagnostic Tests Product Offered Table 71. Invitae Corporation Main Business Table 72. Invitae Corporation Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 73. Invitae Corporation Latest Developments Table 74. Asper Biogene Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 75. Asper Biogene Cystic Fibrosis Diagnostic Tests Product Offered Table 76. Asper Biogene Main Business Table 77. Asper Biogene Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 78. Asper Biogene Latest Developments Table 79. GeneDx Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 80. GeneDx Cystic Fibrosis Diagnostic Tests Product Offered Table 81. GeneDx Main Business Table 82. GeneDx Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 83. GeneDx Latest Developments Table 84. Illumina Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 85. Illumina Cystic Fibrosis Diagnostic Tests Product Offered Table 86. Illumina Main Business Table 87. Illumina Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 88. Illumina Latest Developments Table 89. Elucigene Diagnostics Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 90. Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Product Offered Table 91. Elucigene Diagnostics Main Business Table 92. Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 93. Elucigene Diagnostics Latest Developments Table 94. BillionToOne Inc. Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 95. BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Product Offered Table 96. BillionToOne Inc. Main Business Table 97. BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 98. BillionToOne Inc. Latest Developments Table 99. ELITechGroup Details, Company Type, Cystic Fibrosis Diagnostic Tests Area Served and Its Competitors Table 100. ELITechGroup Cystic Fibrosis Diagnostic Tests Product Offered Table 101. ELITechGroup Main Business Table 102. ELITechGroup Cystic Fibrosis Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 103. ELITechGroup Latest Developments List of Figures Figure 1. Cystic Fibrosis Diagnostic Tests Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cystic Fibrosis Diagnostic Tests Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Cystic Fibrosis Diagnostic Tests Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Cystic Fibrosis Diagnostic Tests Sales Market Share by Country/Region (2022) Figure 8. Cystic Fibrosis Diagnostic Tests Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type in 2022 Figure 10. Cystic Fibrosis Diagnostic Tests in Hospitals Figure 11. Global Cystic Fibrosis Diagnostic Tests Market: Hospitals (2018-2023) & ($ Millions) Figure 12. Cystic Fibrosis Diagnostic Tests in Diagnostic Laboratories Figure 13. Global Cystic Fibrosis Diagnostic Tests Market: Diagnostic Laboratories (2018-2023) & ($ Millions) Figure 14. Cystic Fibrosis Diagnostic Tests in Others Figure 15. Global Cystic Fibrosis Diagnostic Tests Market: Others (2018-2023) & ($ Millions) Figure 16. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application in 2022 Figure 17. Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Player in 2022 Figure 18. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share by Regions (2018-2023) Figure 19. Americas Cystic Fibrosis Diagnostic Tests Market Size 2018-2023 ($ Millions) Figure 20. APAC Cystic Fibrosis Diagnostic Tests Market Size 2018-2023 ($ Millions) Figure 21. Europe Cystic Fibrosis Diagnostic Tests Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size 2018-2023 ($ Millions) Figure 23. Americas Cystic Fibrosis Diagnostic Tests Value Market Share by Country in 2022 Figure 24. United States Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Region in 2022 Figure 29. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type in 2022 Figure 30. APAC Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application in 2022 Figure 31. China Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 35. India Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Country in 2022 Figure 38. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Figure 39. Europe Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Figure 40. Germany Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 41. France Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size Market Share by Application (2018-2023) Figure 48. Egypt Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Cystic Fibrosis Diagnostic Tests Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 54. APAC Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 55. Europe Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 57. United States Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 58. Canada Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 59. Mexico Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 60. Brazil Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 61. China Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 62. Japan Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 63. Korea Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 65. India Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 66. Australia Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 67. Germany Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 68. France Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 69. UK Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 70. Italy Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 71. Russia Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 72. Spain Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 73. Egypt Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 74. South Africa Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 75. Israel Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 76. Turkey Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Cystic Fibrosis Diagnostic Tests Market Size 2024-2029 ($ Millions) Figure 78. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Cystic Fibrosis Diagnostic Tests Market Size Market Share Forecast by Application (2024-2029)
